#glp1 #healthcare #lindayaccarino #x #technology #business #weightloss #leadership #finance
Former X CEO Linda Yaccarino says GLP-1 medications could become one of the most important healthcare interventions of a generation, and she’s now betting her next chapter on that future.
In this episode of Power Players, Yahoo Finance Executive Editor Brian Sozzi sits down with eMed Population Health CEO Linda Yaccarino to discuss healthcare costs, GLP-1 adoption, leadership, and what she learned transforming X under Elon Musk.
Chapters
00:00 Linda Yaccarino’s new healthcare mission
00:48 Why GLP-1 drugs are changing healthcare
02:12 The rising cost of chronic disease
03:38 Why Yaccarino left X for healthcare
06:16 The future of GLP-1 expansion
08:35 Building eMed and scaling growth
09:55 Tom Brady’s role at eMed
12:10 Pitching investors on healthcare transformation
14:37 Why patients stop taking GLP-1 drugs
17:03 The future of healthcare and AI
17:17 Linda Yaccarino reflects on leading X
==
— Facebook: https://www.facebook.com/yahoofinance
— X/Twitter: https://x.com/YahooFinance
— Instagram: https://www.instagram.com/yahoofinance/
— TikTok: https://www.tiktok.com/@yahoofinance
— LinkedIn: https://www.linkedin.com/company/yahoo-finance
https://finance.yahoo.com/
source
